01 · The Question
How Do You Invite Participation Without Making People Feel They Should Say Yes?
Researchers need participants. Recruitment therefore has a purpose: you are asking people to consider joining your study.
That creates a tension. An invitation must be clear and sufficiently informative to attract eligible participants, but it should not make participation appear compulsory, exaggerate what the study offers, or make declining unnecessarily difficult.
The ethical problem is rarely solved by simply adding “Participation is voluntary” at the bottom of a recruitment message. Pressure can come from the person delivering the invitation, the setting, repeated requests, incentives, authority relationships, social expectations, or what potential participants think will happen if they decline.
Good recruitment does not require a neutral-sounding invitation that nobody wants to answer. It requires an invitation that informs and invites without improperly steering the decision.
03 · What You Need to Know
Recruitment Is Part of the Ethical Design of the Study
Recruitment begins before informed consent
Recruitment and informed consent are related, but they are not the same event. Recruitment brings a study to someone's attention and invites further consideration. The informed-consent process provides the information and opportunity needed to decide whether to participate.
Ethical problems can therefore arise before anyone sees a consent form.
FDA guidance for clinical investigations treats direct advertising as the beginning of the informed-consent and participant-selection process. It expects institutional review boards to review both the information in recruitment advertisements and the way that information is communicated. CIOMS likewise states that recruitment materials should use language understandable to potential participants and be approved by the research ethics committee.
This has a practical implication: recruitment is not merely a logistical task delegated to whoever can find participants fastest. The method of approaching people is part of the ethical architecture of the research.
Start with the question potential participants actually need answered
A recruitment message does not need to contain the entire consent form. It does need enough accurate information for someone to determine whether they are interested in learning more.
For FDA-regulated clinical investigations, FDA guidance identifies information that may appropriately appear in recruitment advertisements, including the investigator or facility, the condition or purpose under study, summary eligibility criteria, a brief list of participation benefits when appropriate, time or other commitments, location, and contact information.
The exact information required will vary with the study, jurisdiction, ethics committee, and recruitment medium. The governing principle is more general: recruitment should help potential participants make an initial decision about further consideration without misleading them about what the research is or what it offers.
The amount of information given at this stage also needs balance. A recruitment message should not quietly become an incomplete substitute for informed consent. Researchers who need to decide how much information to give before someone decides whether to join should distinguish the initial invitation from the fuller consent process.
Accuracy matters more than enthusiasm
Researchers naturally want recruitment materials to attract attention. That does not justify presenting uncertain benefits as likely outcomes or research interventions as established treatments.
FDA guidance warns against advertisements that state or imply certainty of favorable outcomes or benefits beyond those described in the consent document and protocol. It also cautions against wording that can make investigational products sound proven.
The same principle extends beyond clinical trials. If participation offers no direct benefit to the individual, recruitment should not manufacture one. If benefits are uncertain, uncertainty should remain visible. If compensation is for time or inconvenience, it should not be rhetorically transformed into a prize for joining.
Watch Out
Recruitment language can be factually true and still create a misleading impression through emphasis. Large payment figures, prominent claims about benefits, or emotionally loaded descriptions may dominate information about what participation actually involves.
The recruiter may change the meaning of the invitation
Imagine receiving the same sentence from two people: “Would you consider participating in our study?”
One comes from a researcher you have never met. The other comes from the supervisor who evaluates your performance.
The words are identical. The decision environment is not.
OHRP specifically identifies authority relationships as a potential source of pressure. Employees may worry that participation affects evaluation or advancement, students may feel pressure when others in their class participate, and patients may feel obligated when their physician is also the investigator. The 2024 Declaration of Helsinki similarly calls for particular caution when potential participants have a dependent relationship with the researcher or may consent under duress. In medical research under those circumstances, consent must be sought by an appropriately qualified person independent of that relationship.
This does not mean every pre-existing relationship prohibits recruitment. It means researchers should examine whether the power relationship changes how freely the invitation can be declined and build appropriate safeguards into the recruitment plan.
Make declining uneventful
One useful way to evaluate recruitment is to imagine the process from the perspective of someone who does not want to participate.
Can that person simply ignore the invitation? Can they decline privately? Must they explain why? Will the researcher know who refused? Will a professor, manager, clinician, or gatekeeper see the decision? Will someone ask again?
An ethically strong recruitment process generally avoids making refusal more socially or practically difficult than necessary.
This matters especially in face-to-face settings. Asking each person publicly whether they will participate may produce a very different decision environment from allowing people to respond privately later. Similarly, distributing a survey in a room and waiting visibly for everyone to complete it may convey expectations that were never written into the protocol.
Repeated contact needs justification and boundaries
A reminder is not automatically pressure. People overlook emails, forget appointments, and intend to respond later. Follow-up can therefore be legitimate and may be included in an approved recruitment strategy.
Repeated contact becomes more concerning when a potential participant has already declined, when reminders become increasingly personal or insistent, or when persistence exploits an authority or dependency relationship.
There is no universal number of reminders that turns ethical recruitment into pressure. The appropriate frequency depends on the study, communication channel, population, approved protocol, and applicable institutional requirements.
A useful distinction is between reminding someone that an opportunity remains available and trying to wear down their refusal.
Incentives can motivate without automatically making recruitment unethical
Researchers sometimes become so concerned about undue influence that they assume payment itself is ethically suspicious. That is too simple.
FDA and OHRP both recognize payment for research participation as common and generally acceptable. Payment may compensate participants for time, inconvenience, discomfort, expenses, or other burdens. What requires review is the amount, purpose, conditions, timing, population, and circumstances in which it is offered.
Payment should also be presented proportionately. FDA guidance for clinical-trial advertisements permits advertisements to state that participants will be paid but advises against emphasizing the payment or amount through unusually prominent visual presentation.
More fundamentally, an attractive offer is not the same thing as a threat. Researchers should distinguish persuasion, undue influence, and coercion rather than calling every strong motivation “coercion.”
Gatekeepers can introduce pressure that the researcher never intended
Researchers often rely on schools, employers, clinics, community organizations, professional associations, or other intermediaries to reach potential participants. These arrangements may be necessary and entirely appropriate.
They can also alter the invitation.
A researcher may send an organization a carefully worded voluntary invitation, only for a manager to announce, “Please make sure everyone completes this survey today.” The researcher's message has not changed, but the recruitment process has.
Where gatekeepers are involved, researchers should clarify what intermediaries may say and do, how invitations will be distributed, whether gatekeepers will know who participates, and how voluntariness will be communicated. The possibility that gatekeepers themselves may create pressure deserves attention during study design, not only after a complaint occurs.
Recruitment procedures should match what the ethics committee approved
Recruitment plans, advertisements, scripts, incentives, and communication procedures may be subject to ethics review under applicable rules. Researchers should therefore use the approved materials and procedures rather than treating recruitment as something they can continuously optimize on their own.
If recruitment is slow, changing the message, increasing incentives, adding a new population, asking supervisors to recruit directly, or switching platforms may alter ethically relevant aspects of the study.
The solution to poor enrollment is not to gradually increase pressure until the sample-size target is reached. When an approved strategy is not working, researchers need to determine what changes require review or approval before the recruitment plan is modified.
